| pubmed-article:16639739 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16639739 | lifeskim:mentions | umls-concept:C0278883 | lld:lifeskim |
| pubmed-article:16639739 | lifeskim:mentions | umls-concept:C0076080 | lld:lifeskim |
| pubmed-article:16639739 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:16639739 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:16639739 | pubmed:dateCreated | 2006-5-29 | lld:pubmed |
| pubmed-article:16639739 | pubmed:abstractText | Temozolomide and interferon-alpha-2b (IFN-alpha-2b) are both active in melanoma. Therefore, the efficacy and safety of temozolomide in combination with pegylated IFN-alpha-2b in patients with metastatic melanoma without brain metastases was investigated. | lld:pubmed |
| pubmed-article:16639739 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16639739 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16639739 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:16639739 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16639739 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16639739 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16639739 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16639739 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16639739 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16639739 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16639739 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16639739 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:16639739 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:16639739 | pubmed:author | pubmed-author:KrownSusan... | lld:pubmed |
| pubmed-article:16639739 | pubmed:author | pubmed-author:HoughtonAlan... | lld:pubmed |
| pubmed-article:16639739 | pubmed:author | pubmed-author:LivingstonPhi... | lld:pubmed |
| pubmed-article:16639739 | pubmed:author | pubmed-author:PanageasKathe... | lld:pubmed |
| pubmed-article:16639739 | pubmed:author | pubmed-author:WolchokJedd... | lld:pubmed |
| pubmed-article:16639739 | pubmed:author | pubmed-author:HwuWen-JenWJ | lld:pubmed |
| pubmed-article:16639739 | pubmed:author | pubmed-author:ChapmanPaul... | lld:pubmed |
| pubmed-article:16639739 | pubmed:author | pubmed-author:MenellJennife... | lld:pubmed |
| pubmed-article:16639739 | pubmed:author | pubmed-author:WilliamsLinda... | lld:pubmed |
| pubmed-article:16639739 | pubmed:author | pubmed-author:LambLynne ALA | lld:pubmed |
| pubmed-article:16639739 | pubmed:author | pubmed-author:AirdSuzanS | lld:pubmed |
| pubmed-article:16639739 | pubmed:copyrightInfo | Copyright (c) 2006 American Cancer Society. | lld:pubmed |
| pubmed-article:16639739 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16639739 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:16639739 | pubmed:volume | 106 | lld:pubmed |
| pubmed-article:16639739 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16639739 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16639739 | pubmed:pagination | 2445-51 | lld:pubmed |
| pubmed-article:16639739 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:16639739 | pubmed:meshHeading | pubmed-meshheading:16639739... | lld:pubmed |
| pubmed-article:16639739 | pubmed:meshHeading | pubmed-meshheading:16639739... | lld:pubmed |
| pubmed-article:16639739 | pubmed:meshHeading | pubmed-meshheading:16639739... | lld:pubmed |
| pubmed-article:16639739 | pubmed:meshHeading | pubmed-meshheading:16639739... | lld:pubmed |
| pubmed-article:16639739 | pubmed:meshHeading | pubmed-meshheading:16639739... | lld:pubmed |
| pubmed-article:16639739 | pubmed:meshHeading | pubmed-meshheading:16639739... | lld:pubmed |
| pubmed-article:16639739 | pubmed:meshHeading | pubmed-meshheading:16639739... | lld:pubmed |
| pubmed-article:16639739 | pubmed:meshHeading | pubmed-meshheading:16639739... | lld:pubmed |
| pubmed-article:16639739 | pubmed:meshHeading | pubmed-meshheading:16639739... | lld:pubmed |
| pubmed-article:16639739 | pubmed:meshHeading | pubmed-meshheading:16639739... | lld:pubmed |
| pubmed-article:16639739 | pubmed:meshHeading | pubmed-meshheading:16639739... | lld:pubmed |
| pubmed-article:16639739 | pubmed:meshHeading | pubmed-meshheading:16639739... | lld:pubmed |
| pubmed-article:16639739 | pubmed:meshHeading | pubmed-meshheading:16639739... | lld:pubmed |
| pubmed-article:16639739 | pubmed:meshHeading | pubmed-meshheading:16639739... | lld:pubmed |
| pubmed-article:16639739 | pubmed:meshHeading | pubmed-meshheading:16639739... | lld:pubmed |
| pubmed-article:16639739 | pubmed:meshHeading | pubmed-meshheading:16639739... | lld:pubmed |
| pubmed-article:16639739 | pubmed:meshHeading | pubmed-meshheading:16639739... | lld:pubmed |
| pubmed-article:16639739 | pubmed:meshHeading | pubmed-meshheading:16639739... | lld:pubmed |
| pubmed-article:16639739 | pubmed:meshHeading | pubmed-meshheading:16639739... | lld:pubmed |
| pubmed-article:16639739 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16639739 | pubmed:articleTitle | Phase II study of temozolomide plus pegylated interferon-alpha-2b for metastatic melanoma. | lld:pubmed |
| pubmed-article:16639739 | pubmed:affiliation | Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. wenjhwu@mdanderson.org | lld:pubmed |
| pubmed-article:16639739 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16639739 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:16639739 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:16639739 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16639739 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16639739 | lld:pubmed |
